1. Home
  2. HPI vs RCEL Comparison

HPI vs RCEL Comparison

Compare HPI & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HPI

John Hancock Preferred Income Fund of Beneficial Interest

N/A

Current Price

$12.71

Market Cap

360.0M

Sector

Finance

ML Signal

N/A

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

N/A

Current Price

$15.67

Market Cap

403.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HPI
RCEL
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
360.0M
403.3M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
HPI
RCEL
Price
$12.71
$15.67
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $20.10
AVG Volume (30 Days)
116.9K
★ 540.5K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 27.20
EPS
★ N/A
N/A
Revenue
N/A
★ $71,610,000.00
Revenue This Year
N/A
$33.44
Revenue Next Year
N/A
$21.95
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 11.45
52 Week Low
$12.83
$3.22
52 Week High
$17.07
$18.43

Technical Indicators

Market Signals
Indicator
HPI
RCEL
Relative Strength Index (RSI) 31.64 54.17
Support Level N/A $14.67
Resistance Level $16.39 $16.90
Average True Range (ATR) 0.23 1.23
MACD -0.00 -0.13
Stochastic Oscillator 22.95 28.72

Price Performance

Historical Comparison
HPI
RCEL

About HPI John Hancock Preferred Income Fund of Beneficial Interest

John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: